News

Videos

Carmot Therapeutics – developing novel dual incretin modulators to transform diabetes care

Carmot Therapeutics – developing novel dual incretin modulators to transform diabetes care
Making what matters possible.

Carmot Therapeutics Inc.
A Member of the Roche Group
740 Heinz Avenue
Berkeley, CA 94710
[email protected]

©2024 Carmot Therapeutics, Inc. All Rights Reserved.
Privacy Policy Terms of Use Site Design: Monderer Design